Diamond-Blackfan anemia is a congenital disorder of erythropoiesis in humans, characterized by a macrocytic anemia often associated with physical anomalies. Mutations at either the W or Steel loci in the mouse also leads to a severe macrocytic anemia, as well as other developmental abnormalities. The W locus encodes the proto-oncogene c-kit, a member of the receptor tyrosine kinase family, while the Steel locus encodes a potent hematopoietic growth factor that is the ligand for c-kif. Growth of clonogenic marrow erythroid progenitor cells in vitro in the presence of the recombinant hematopoietic growth factors interleukin-3 (IL-3) and Steel was used to characterize this disease at the cellular level. Three patterns of in vitro marrow response to both recombinant IL-3 or Steel were observed among 10 Diamond-ONSTITUTIONAL PURE red blood cell (RBC) apla-C sia, or Diamond-Blackfan anemia, is a severe congenita1 abnormality of erythropoiesis characterized by a macrocytic anemia developing early in childhood.' The bone marrows of affected individuals have markedly reduced or absent RBC precursors, with normal marrow cellularity and preservation of other hematopoietic cell lineages.2s3 Although most cases are sporadic, there is evidence for both autosomal dominant and recessive inheritan~e.'.~ Associated anomalies, one or more of which has been described in 70% of reported cases of Diamond-Blackfan anemia, include abnormalities of the skeletal system, jaw and mouth, eyes, kidneys, and heart; dwarfism, cartilage-hair hypoplasia, and hypogonadism have also been reported.' The molecular basis for this syndrome has not been determined, nor is it clear, given the heterogeneity in associated abnormalities, whether Diamond-Blackfan anemia is a homogeneous disorder resulting from mutations in a single gene, or several distinct diseases that result from mutations in different genes.
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In the mouse, mutations at either the W or Steel (SI) loci also lead to a severe macrocytic anemia that can be inherited in either a dominant (eg, the Wv allele) or recessive (eg, W57) manner.' In addition, these mice have associated abnormalities, including defects in mast cells, coat color, and germ cells.' Previous marrow transplantation and embryonic chimera experiments have shown that W mutants have a cell-autonomous, intrinsic defect in the stem cells that gives rise to erythrocytes, melanocytes, and germ cells, whereas SI mice have a defect in the microenvironment in which these cells develop and function.' Recently, molecular analyses of these loci have established that W encodes the c-kit growth factor receptor,6." while S1 encodes the ligand that binds to the Kit receptor,"-I6 resulting in the activation of the intrinsic tyrosine kinase activity of c-kit. '7,18 As expected from the anemic phenotype of mice with mutations at the SI locus, the protein product of the SI gene, alternatively called mast cell growth factor, stem cell factor, or the Kit ligand, and referred to in this report as Steel, has profound biologic effects on hematopoietic progenitor cells both in vitro and in the intact anima1.1'.'6.'9
Blackfan patients: those that responded quantitatively and qualitatively almost as well as cells from normal marrow, those that responded at an intermediate level, and those that did not respond at all. These results provide evidence for cellular heterogeneity underlying the pathogenesis of this disorder and therefore raise the possibility that there may be more than one underlying molecular basis for the disease. No gross abnormalities in the structure of either the c-kit or Steel loci were observed in these patients. The normal response in culture of the progenitor cells from at least some patients to Steel with or without IL-3 raises the possibility of using this novel growth factor as a therapeutic agent in Diamond-Blackfan anemia. 6 1991 by The American Society of Hematology.
Furthermore, while mast cells or marrow cells from normal or mutant SI mice proliferate in response to Steel factor in vitro, cells from mice with severe mutations at the W/c-kit locus do not proliferate in response to Steel."'I6 Given the overlap in phenotypes of Wand SI mutant mice with that of individuals with Diamond-Blackfan anemia, we sought to determine whether this disease might arise as the result of mutation in some step in the c-kit signal transduction pathway by investigating the ability of hematopoietic progenitor cells from affected patients to proliferate in response to Steel factor in culture. We show that patients with this disease can be grouped into three categories on the basis of the ability of their marrow cells to respond to Steel in cultures. This heterogeneity in response to Steel may serve as a useful parameter to characterize and categorize Diamond-Blackfan anemia. In addition, these data suggest that this new hematopoeitic growth factor either alone, or in concert with other factors, may be a powerful therapeutic agent for this disease. Laboratories, Vancouver, Canada) was added at a final concentration of 2 U/mL. Where indicated, recombinant interleukin-3 (IL-3), kindly provided by S. Clark (Genetics Institute, Cambridge, MA) was added. The Steel factor was expressed in yeast and purified as described. 16 The cultures were incubated at 37°C with 5% CO, and high humidity. Colonies were counted on day 7 (CFU-E) and 14 (BFU-E) using an inverted microscope. A CFU-E colony was defined as a cluster of eight or more hemoglobinized cells on day 7; a BFU-E colony consisted of either a single aggregate of 500 or more hemoglobinized cells, or three or more smaller subcolonies on day 14.
Serum-free culture conditions. Colony assays in serum-free conditions were performed as described." Briefly, bone marrow cells were separated as described previously and suspended in a medium, 1% defatted BSA, human transferrin, lipids, antioxidants, and antibodies, in the presence of the indicated growth factors, in 0.8% methylcellulose, and cultured in 1.5 X 1.0 cm plastic wells.
RESULTS
In vitro response of normal and Diamond-Blackfan anemia marrow cells to Steel. To assess the ability of hematopoietic cells to respond to Steel, we obtained marrow samples from 10 steroid-unresponsive, transfusion-dependent patients with Diamond-Blackfan anemia (Table l) . Also, control bone marrow was aspirated from one healthy adult volunteer. The ability of these cells to respond to either Steel alone, or in combination with the recombinant hematopoietic growth factor IL-3, was determined by performing clonogenic assays (CFU-E and BFU-E assays) in semisolid methylcellulose medium in vitro. Cell cultures of bone marrow from a normal adult volunteer gave rise to mean CFU-E and BFU-E colony numbers (+SD) of 135 + 1 and 123 f 13 per lo5 cells plated, respectively (Table 2) in the presence of purified human EPO. Normal marrow cells grown in both EPO and recombinant IL-3 (10 U/mL) showed no increase in the number of CFU-E compared to cultures with EPO alone assayed on day 7, and a 41% increase in the number of BFU-E assayed on day 14 ( Table  2 ). These observations are in agreement with previous results on the growth of normal marrow progenitor cells in the presence of these growth When normal marrow cells were plated in increasing concentrations of recombinant soluble Steel (ranging from 12.5 to 100 ng/mL), there was an increase in the number of BFU-E, with no dose response observed ( Table 2) . Growth in the presence of both Steel and IL-3 resulted in a large increase in the number of BFU-E observed on day 14 ( Table 2 ). More striking than the increase in numbers of BFU-E (and mixed-lineage colonies) was the very dramatic increase in the size and degree of hemoglobinization of the colonies. Very large, macroscopically visible pure and mixed lineage colonies containing between lo3 and lo4 cells of erythroid, granulocytic, macrophage, and undifferentiated morphology were also observed in response to growth in Steel plus IL-3 plus EPO (Fig 1) .
We next examined the response of marrow progenitor cells from patients with Diamond-Blackfan anemia to the recombinant Steel protein. As described p r e v i o~s l y ,~,~.~~,~ the number of erythroid progenitor cells from patients with Diamond-Blackfan anemia was, in general, markedly reduced when compared with normal marrow ( Table 2) . Patients D.B., C.B., R.T., and J.R. had low, but detectable, numbers of CFU-E and BFU-E when cultured in the presence of EPO. The colony numbers in these patients increased markedly when IL-3 was added to the culture media ( Table 1) Table 2) .
These same marrow samples were simultaneously plated in the presence of recombinant Steel protein, either with EPO alone, or in combination with IL-3. Table 2 shows that three discrete patterns of response were observed. The same four patients that responded well to IL-3 also showed a marked increase in the number of BFU-E when grown in Steel, two patients had a more moderate response, with only a slight elevation of their BFU-E numbers, and the remaining four patients that failed to respond to IL-3 also had no response to Steel.
Despite these quantitative differences between normal and Diamond-Blackfan marrow, the addition of Steel resulted in the same dramatic increase in colony size and hemoglobinization that was observed for normal marrow Steel (50 ng/mL) 1 6 8 2 2 8 8 0 2 2 8 6 2 2 7 1 2 9 1 1 7 2 1 7 4 1 2 2 4 2 2 4 7 2 Bone marrow cells from a healthy volunteer and 10 patients with Diamond-Blackfan anemia were grown in semisolid culture media containing fetal calf serum and the growth factors indicated. At day 14, the numbers of BFU-E were determined. (Fig 1) . In addition, the addition of Steel promoted the growth of multilineage colonies from cells derived from patients with Diamond-Blackfan anemia.
The experiments presented in Table 2 were performed in the presence of fetal calf serum which might contain growth factors that interact synergistically with Steel or IL-3 to produce the results shown in Table 1 . Therefore, we repeated these clonogenic assays in an improved serum-free medium, as described in Materials and Methods. As shown in Table 3 , bone marrow cells from patient R.T. who responded to Steel in medium containing serum ( Table 2 ) also showed an increase in the numbers of erythroid colonies under serumfree conditions.
Response to Steel in serum-free medium.
Southem blot analysis of the c-kit and S1genes in DiamondBlackfan patients. It is interesting to speculate whether any of the patients examined in this study have anemia as the result of mutation in either the human Wor SI loci. For example, those patients who responded normally in culture to Steel might have a mutation in the S1 locus itself. To determine whether any of the individuals in our study had gross rearrangements in either the SI or c-kit gene, Southem blot analysis was performed on DNA isolated from Epstein-Barr virus (EBV)-immortalized lymphoblastoid cells derived from seven patients with Diamond-Blackfan anemia. As shown in Fig 2, no alterations in either gene was detected at the level of resolution of genomic Southern blot analysis. Table 1 Eone marrow cells from a healthy volunteer and a child with Diamond-Blackfan anemia were grown as described.a'0 The numbers of CFU-E and EFU-E were determined on daya 7 and 14, respectively.
DISCUSSION
Thc rcsults prcscntcd hcrc suggest that DiamondBlackfan patients can bc dividcd into thrcc discrctc groups:
thosc that rcspond wcll to thc addition of Stccl in culturc, thosc that rcspond only modcratcly wcll, and thosc that do not appcar to rcspond at all. Of thc 10 paticnts that wc cxamincd in this scrics of cxpcrimcnts, six fell into thc first and sccond catcgorics, whilc the remaining four fcll into the third category. Thcsc diflcrcnccs in colony numbcr in rcsponsc to Stccl cannot hc accounted for by thc agc of the paticnt at thc timc of study, nor can wc idcntify any othcr variablc that might cxplain thcsc obscrvations. Thus, the diflcrcnccs in crythroid pmgcnitor prolifcration in bonc marrow culturcs may rcflcct a truc hctcrogcncity in thc pathogcncsis of Diamond-Rlackfan ancmia. This conclusion cxtcnds carlicr ohscrvations showing hctcrogcncity in thc rcsponsc of marrow cclls from thcsc paticnts to 11--3.'-' Strikingly, thcrc was an cxccllcnt corrclation bctwccn thosc paticnts that rcspondcd to IL-3 and thosc that rcspondcd to Stccl in culturc. In contrast, murine W mutants fail to rcspond normally to Stccl. hut rctain thcir ability to rcspond to IL-3. Thus, onc interpretation of our rcsults is that thc primary dcfcct in thcsc paticnts lcads to a partial or complctc abscncc of progcnitor cclls. and hcncc an inability to rcspond in culturc to any hcmatopoictic growth factor. This primaty dcfcct could bc in the c4ir signaling pathway itsclf or. in a sccond. unrclatcd. pathway that also controls thc proliferation and diflcrcntiation of crythroid progcnitor cclls.
Bccausc thc SI dcfcct in thc mousc lcads to a dcfcct in thc cnvironmcnt in which hcmatopoictic stem cclls function. thcir ancmia Cannot bc curcd by bonc marrow transplantation.""' Thcrc havc bccn a numbcr of cascs in which paticnts with Diamond-Rlackfan ancmia havc bccn succcssfully curcd by honc marrow transplantation.h ." suggcsting that. in thcsc paticnts. thc dcfcct is not in the hcmatopoictic micracnvironmcnt and hcncc docs not appcar to bc in thc human S I locus itsclf. It clcarly would bc of intcrcst to dctcrminc whcthcr thcrc is any relationship bctwccn thc ability to rcspond to Stccl in culturc and thc succcssof bonc marrow cngraftmcnt aftcr transplantation.
Although thc ccllular charactcrization of marrow progenitor cclls dcscribcd in this rcport docs not providc dirca information conccrning thc molccular basis of thc dcfcct in Diamond-Blackfan discasc, two important conclusions can bc drawn from thcsc cxpcrimcnts. First, Diamond-Rlackfan ancmia is a hctcrogcncous diwrdcr at thc hcmatopoictic progcnitor ccll Icvcl. This hctcropcncity may indicatc that this diwrdcr is not a singlc entity. hut rather can arisc as the rcsult of mutation in onc of scvcral gcncs. Sccond. a significant proportion of paticnts with this discasc rcspondcd almost normally to thc Stccl factor in culturc. Thc administration of recombinant Stccl factor to cithcr micc" For personal use only. on October 23, 2017. by guest www.bloodjournal.org From or nonhuman primates3' leads to an elevation in the number of hematopoietic cells of both the myeloid and lymphoid lineages. In addition, recombinant soluble Steel protein can at least partially correct the macrocytic anemia in mutant SI mice.I5 The in vivo biologic effects of this new hematopoietic growth factor, together with the characterization of Diamond-Blackfan patients by the in vitro colony assays described here, may provide a means for identifying those individuals who might be suitable candidates for therapy with recombinant Steel.
